tiprankstipranks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
Holding LEXX?
Track your performance easily

Lexaria Bioscience (LEXX) Financial Statements

178 Followers

Lexaria Bioscience Financial Overview

Lexaria Bioscience's market cap is currently ―. The company's EPS TTM is $-1.128; its P/E ratio is -1.91; Lexaria Bioscience is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
May 24Feb 24Nov 23Aug 23May 23
Income Statement-
Total Revenue$ 84.00K$ 145.00K$ 151.28K$ -104.91K$ 77.71K
Gross Profit$ 84.00K$ 145.00K$ 146.46K$ -104.91K$ 64.96K
EBIT$ -1.78M$ -652.73K$ -1.19M$ -1.35M$ -2.39M
EBITDA$ -1.77M$ -636.80K$ -1.16M$ -1.28M$ -2.36M
Net Income Common Stockholders$ -1.78M$ -652.73K$ -1.18M$ -1.34M$ -2.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.51M$ 4.79M$ 2.03M$ 1.48M$ 3.43M
Total Assets$ 10.02M$ 6.35M$ 3.63M$ 3.08M$ 5.24M
Total Debt$ 142.59K$ 148.88K$ 155.07K$ 163.97K$ 174.90K
Net Debt$ -8.36M$ -4.64M$ -1.87M$ -1.31M$ -3.26M
Total Liabilities$ 271.38K$ 204.20K$ 254.04K$ 403.91K$ 1.20M
Stockholders Equity$ 10.12M$ 6.52M$ 3.74M$ 3.04M$ 4.40M
Cash Flow-
Free Cash Flow$ -1.29M$ -676.60K$ -1.22M$ -1.69M$ -1.82M
Operating Cash Flow$ -1.27M$ -619.61K$ -1.18M$ -1.62M$ -1.79M
Investing Cash Flow$ -22.00K$ -56.99K$ -40.03K$ -68.44K$ -33.65K
Financing Cash Flow$ 5.04M$ 3.45M$ 1.82M$ -121.69K$ 1.71M
Currency in USD

Lexaria Bioscience Earnings and Revenue History

Lexaria Bioscience Debt to Assets

Lexaria Bioscience Cash Flow

Lexaria Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis